<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Walker JM</submitter><funding>National Institute of Neurological Disorders and Stroke</funding><funding>BLRD VA</funding><funding>NIA NIH HHS</funding><funding>NINDS NIH HHS</funding><funding>National Institute on Aging</funding><pagination>783-797</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10916977</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>20(2)</volume><pubmed_abstract>&lt;h4>Introduction&lt;/h4>Alzheimer's disease (AD) and primary age-related tauopathy (PART) both harbor 3R/4R hyperphosphorylated-tau (p-tau)-positive neurofibrillary tangles (NFTs) but differ in the spatial p-tau development in the hippocampus.&lt;h4>Methods&lt;/h4>Using Nanostring GeoMx Digital Spatial Profiling, we compared protein expression within hippocampal subregions in NFT-bearing and non-NFT-bearing neurons in AD (n = 7) and PART (n = 7) subjects.&lt;h4>Results&lt;/h4>Proteomic measures of synaptic health were inversely correlated with the subregional p-tau burden in AD and PART, and there were numerous differences in proteins involved in proteostasis, amyloid beta (Aβ) processing, inflammation, microglia, oxidative stress, and neuronal/synaptic health between AD and PART and between definite PART and possible PART.&lt;h4>Discussion&lt;/h4>These results suggest subfield-specific proteome differences that may explain some of the differences in Aβ and p-tau distribution and apparent pathogenicity. In addition, hippocampal neurons in possible PART may have more in common with AD than with definite PART, highlighting the importance of Aβ in the pathologic process.&lt;h4>Highlights&lt;/h4>Synaptic health is inversely correlated with local p-tau burden. The proteome of NFT- and non-NFT-bearing neurons is influenced by the presence of Aβ in the hippocampus. Neurons in possible PART cases share more proteomic similarities with neurons in ADNC than they do with neurons in definite PART cases.</pubmed_abstract><journal>Alzheimer's &amp; dementia : the journal of the Alzheimer's Association</journal><pubmed_title>Spatial proteomics of hippocampal subfield-specific pathology in Alzheimer's disease and primary age-related tauopathy.</pubmed_title><pmcid>PMC10916977</pmcid><funding_grant_id>R21 AG078505</funding_grant_id><funding_grant_id>R01 AG065839</funding_grant_id><funding_grant_id>P30 AG066546</funding_grant_id><funding_grant_id>U54 AG079754</funding_grant_id><funding_grant_id>P30 AG066514</funding_grant_id><funding_grant_id>I01 BX005717</funding_grant_id><funding_grant_id>R01 AG068293</funding_grant_id><funding_grant_id>R21 NS125171</funding_grant_id><funding_grant_id>R24 AG073199</funding_grant_id><funding_grant_id>T32 AG049688</funding_grant_id><funding_grant_id>P30 AG066512</funding_grant_id><funding_grant_id>P01 AG060882</funding_grant_id><funding_grant_id>K01 AG070326</funding_grant_id><funding_grant_id>P30 AG044271</funding_grant_id><pubmed_authors>Orr ME</pubmed_authors><pubmed_authors>Walker JM</pubmed_authors><pubmed_authors>Marx GA</pubmed_authors><pubmed_authors>Daoud EV</pubmed_authors><pubmed_authors>Ehrenberg AJ</pubmed_authors><pubmed_authors>Orr TC</pubmed_authors><pubmed_authors>Vij M</pubmed_authors><pubmed_authors>White CL</pubmed_authors><pubmed_authors>Farrell K</pubmed_authors><pubmed_authors>Christie TD</pubmed_authors><pubmed_authors>Selmanovic E</pubmed_authors><pubmed_authors>Wisniewski T</pubmed_authors><pubmed_authors>Yokoda RT</pubmed_authors><pubmed_authors>Kauffman J</pubmed_authors><pubmed_authors>Crary JF</pubmed_authors><pubmed_authors>Kautz TF</pubmed_authors><pubmed_authors>Thorn EL</pubmed_authors><pubmed_authors>McKenzie AT</pubmed_authors><pubmed_authors>Richardson TE</pubmed_authors><pubmed_authors>Drummond E</pubmed_authors></additional><is_claimable>false</is_claimable><name>Spatial proteomics of hippocampal subfield-specific pathology in Alzheimer's disease and primary age-related tauopathy.</name><description>&lt;h4>Introduction&lt;/h4>Alzheimer's disease (AD) and primary age-related tauopathy (PART) both harbor 3R/4R hyperphosphorylated-tau (p-tau)-positive neurofibrillary tangles (NFTs) but differ in the spatial p-tau development in the hippocampus.&lt;h4>Methods&lt;/h4>Using Nanostring GeoMx Digital Spatial Profiling, we compared protein expression within hippocampal subregions in NFT-bearing and non-NFT-bearing neurons in AD (n = 7) and PART (n = 7) subjects.&lt;h4>Results&lt;/h4>Proteomic measures of synaptic health were inversely correlated with the subregional p-tau burden in AD and PART, and there were numerous differences in proteins involved in proteostasis, amyloid beta (Aβ) processing, inflammation, microglia, oxidative stress, and neuronal/synaptic health between AD and PART and between definite PART and possible PART.&lt;h4>Discussion&lt;/h4>These results suggest subfield-specific proteome differences that may explain some of the differences in Aβ and p-tau distribution and apparent pathogenicity. In addition, hippocampal neurons in possible PART may have more in common with AD than with definite PART, highlighting the importance of Aβ in the pathologic process.&lt;h4>Highlights&lt;/h4>Synaptic health is inversely correlated with local p-tau burden. The proteome of NFT- and non-NFT-bearing neurons is influenced by the presence of Aβ in the hippocampus. Neurons in possible PART cases share more proteomic similarities with neurons in ADNC than they do with neurons in definite PART cases.</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Feb</publication><modification>2026-06-27T03:18:23.019Z</modification><creation>2026-06-27T03:06:20.827Z</creation></dates><accession>S-EPMC10916977</accession><cross_references><pubmed>37777848</pubmed><doi>10.1002/alz.13484</doi></cross_references></HashMap>